Saundra Pelletier, Evofem CEO
Evofem's approved birth control gel flops PhIII for STI prevention, early 2023 filing plans ditched
A biotech with an approved non-hormonal birth control gel had hoped it would be at the FDA’s doorsteps in early 2023 to request a label …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.